Microbio Co., Ltd. (TPEX:4128)
Taiwan · Delayed Price · Currency is TWD 17.15
-0.60 (-3.38%)
Apr 17, 2026, 1:30 PM CST
Microbio Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -757.75 | -1,101 | -1,180 | 211.2 | 49.42 |
Depreciation & Amortization | 267.22 | 261.03 | 240.07 | 237.87 | 265.07 |
Other Amortization | 7.48 | 5.55 | 5.33 | 4.61 | 5.14 |
Loss (Gain) From Sale of Assets | -6.68 | -4.6 | 0.01 | 2.1 | 1.43 |
Asset Writedown & Restructuring Costs | 8.54 | - | - | - | -3.7 |
Loss (Gain) From Sale of Investments | 14.17 | 3.21 | -65.97 | -22.39 | 8.19 |
Loss (Gain) on Equity Investments | 571.46 | 933.23 | 1,052 | -235.94 | -719.45 |
Stock-Based Compensation | 22.95 | 3.6 | 0.4 | 0.11 | 820.6 |
Other Operating Activities | -250.58 | -181.26 | -221.21 | -55.96 | -488.15 |
Change in Accounts Receivable | 225.05 | -219.62 | 11.84 | 2.11 | -12.42 |
Change in Inventory | -46.13 | -22.75 | 12.75 | -11.53 | -6.09 |
Change in Accounts Payable | 31.65 | -23.35 | 44.06 | -7.38 | 10.92 |
Change in Unearned Revenue | -37.15 | 843.53 | -5.53 | 2.7 | 82.39 |
Change in Other Net Operating Assets | 35.04 | 32.13 | -12.77 | 14.07 | 40.63 |
Operating Cash Flow | 85.27 | 529.9 | -118.75 | 141.57 | 53.98 |
Operating Cash Flow Growth | -83.91% | - | - | 162.25% | -50.84% |
Capital Expenditures | -60.79 | -22.58 | -44.78 | -38.88 | -87.22 |
Sale of Property, Plant & Equipment | 0.03 | 0.07 | 0.08 | 10.28 | 0.08 |
Divestitures | - | 25.93 | - | - | - |
Sale (Purchase) of Intangibles | -8.43 | -17.66 | -3.27 | -4.24 | -16.75 |
Sale (Purchase) of Real Estate | 83.93 | - | - | - | - |
Investment in Securities | 91.3 | -292.54 | -211.74 | 318.31 | -49.2 |
Other Investing Activities | 11.01 | 4.73 | 48.7 | 49.09 | 160.68 |
Investing Cash Flow | 117.05 | -302.05 | -211 | 334.56 | 7.6 |
Short-Term Debt Repaid | - | - | - | - | -1 |
Long-Term Debt Repaid | -161.28 | -157 | -135.25 | -134.94 | -131.3 |
Total Debt Repaid | -161.28 | -157 | -135.25 | -134.94 | -132.3 |
Net Debt Issued (Repaid) | -161.28 | -157 | -135.25 | -134.94 | -132.3 |
Issuance of Common Stock | - | - | - | 94.16 | 108.87 |
Common Dividends Paid | - | - | -20.44 | -18.65 | - |
Other Financing Activities | -9 | -9.87 | -7.38 | -7.69 | -18.77 |
Financing Cash Flow | -170.28 | -166.86 | -163.08 | -67.12 | -42.19 |
Foreign Exchange Rate Adjustments | 5.81 | -4.75 | -22.2 | -2.64 | 26.65 |
Net Cash Flow | 37.86 | 56.24 | -515.03 | 406.36 | 46.05 |
Free Cash Flow | 24.49 | 507.32 | -163.53 | 102.69 | -33.24 |
Free Cash Flow Growth | -95.17% | - | - | - | - |
Free Cash Flow Margin | 1.29% | 29.45% | -10.28% | 5.96% | -1.86% |
Free Cash Flow Per Share | 0.04 | 0.86 | -0.28 | 0.17 | -0.06 |
Cash Interest Paid | 11.73 | 10.13 | 7.38 | 6.1 | 6.23 |
Cash Income Tax Paid | 1.56 | 0.58 | 0.93 | -4.74 | 0.01 |
Levered Free Cash Flow | 30.77 | -231.35 | -93.53 | 144.66 | 325.54 |
Unlevered Free Cash Flow | 38.1 | -225.02 | -88.92 | 148.47 | 329.43 |
Change in Working Capital | 208.46 | 609.94 | 50.36 | -0.04 | 115.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.